Trials / Unknown
UnknownNCT00397397
Comparative Treatment Study in Patients With Lower Ureteral Stones
Comparative Study in Patients With Lower Ureteral Stones Treated With 10 MG Alfuzosin,10 MG Alfuzosin With Rowatinex, and Rowatinex Alone
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (planned)
- Sponsor
- Hillel Yaffe Medical Center · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
We wish to determine the best treatment for expulsion of lower ureteral stones. Which of the three major treatment protocols is the best treatment of conservative management of ureteral stones?
Detailed description
The study will include 60 patients with lower ureteral stones. The patients will be divided into three groups. The first group will be administered Alfuzosin (10 mg). The second group will be administered a combination of Alfuzosin (10 mg)and Rowatinex (Pinene 31%, Camphene 15%, Anetol 4%, Borneol 10%, Cineol 3%, Fenchenol 4%, Olive Oil 33%). The third group will be administered Rowatinex.
Conditions
Timeline
- Start date
- 2007-01-01
- Completion
- 2007-03-01
- First posted
- 2006-11-09
- Last updated
- 2006-11-09
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00397397. Inclusion in this directory is not an endorsement.